.

Pro-Cell

.

Essential Information

View Research

View Directions

Ordering

1 14ml bottle:

$59.95

Order Pro-Cell

Orders, if not shipped the same day, are sent out next business day. To order by phone or if you have any questions, please call:

1-813-973-0996

.


View More Pictures

Introducing Pro-Cell 40 - 99+% Pure Liquid DHEA

Developed and manufactured by Discovery Experimental & Development Inc., Pro-Cell 40 is liquid Dehydroepiandrosterone (DHEA) of the highest purity. Strictly Supplements believes that this DHEA product is the highest purity DHEA in the world, and also the most effective DHEA in the world.

The structure of Pro-Cell 40 alone easily makes it superior to all DHEA products on the market. All entities that make up the solution used to hold, stabilize, & transport the DHEA are at 99.9% purity or higher. Pro-Cell 40 utilizes the best and most effective administration method possible for consumers (second to direct infusion into the blood). The sublingual administration method ensures that the DHEA is absorbed directly into the blood stream. Because of it's extreme purity, Pro-Cell 40 is inherently stable. Pro-Cell 40 produced by Discovery Experimental in the 1990's still retains it's structure and effectiveness.

Dehydroepiandrosterone - DHEA at 99+% Purity

Scientists worldwide have been conducting clinical trials using various formulations of DHEA. There are thousands of trials in medical databases around the world. Despite the FDA's heavy restrictions on displaying crucial information regarding DHEA, some facts found in clinical trials may be disclosed.

Clinical trials show as DHEA levels drop, cell degeneration escalates and the immune system degenerates. As DHEA essentially seems to affect hormone products, which in turn affects all vital organs, skin, and bone tissue, it is not difficult to hypothesize what happens to the body as DHEA levels deplete.

Clinical trials show DHEA regulates many steroid hormones including stress hormones (cortisol, norepinephrine), sex hormones (estrogen, testosterone), and DHEA plays a major role in burning fat, and stimulating bone growth.

Low DHEA levels have been reported in some individuals with:

  1. anorexia
  2. end-stage kidney disease
  3. type 2 diabetes (non-insulin dependent diabetes)
  4. AIDS
  5. adrenal insufficiency
  6. in the critically ill
  7. DHEA levels may also be depleted by a number of drugs, including insulin, corticosteroids, opiates, and danazol

- National Institutes of Health (NIH) - Medline

Alleged DHEA Dangers

Many supplement companies and organizations seem to be advertising listless dangers of DHEA. There is an increase of articles dedicated to displaying DHEA as a substance with "risks that outweigh the benefits." Strictly Supplements believes these articles exist to promote the much less expensive DHEA precursors. These DHEA precursors are advertised as producing "the effects of DHEA without the risks".

Nearly every "danger" that is advertised is a very extreme exaggeration. It needs to be understood that most of these adverse side-effects could occur only as a result of taking improper doses of DHEA. DHEA regulates many functions that take place within the body. It's quite obvious that if the body is being overloaded with DHEA adverse side-effects will occur.

Pro-Cell 40 comes with very accurate dosage instructions. These instructions were written by doctors under the employ of a pharmaceutical company. These doctors extensively researched DHEA in general. They then conducted quite a few tests on Pro-Cell 40. Only after gathering great amounts of scientific data did they write up a dosage chart. This dosage chart has been tested and in existence for many years. It is extremely accurate, only very few cases of abnormal hair growth have been reported in the past 13 years. All cases were immediately resolved after lowering dosages.

Strictly Supplements recommends all customers visit a health care professional to assess the most accurate dose for your body. However, it is not required, as the dosage chart Strictly Supplements provides is very precise.

DEDI's Report - The Benefits of 99+% Pure DHEA

Discovery Experimental, developers of Pro-Cell 40, extensively researched DHEA to understand it's benefits and what it may be effective against. This research was conducted many years ago and is still, of course, valid. It is possible that research since has discovered a few more conditions that DHEA may be effective against, but only a few at most. This research has been verified and proven.

DHEA and Cardiovascular Disease

Atherosclerosis is a proliferative disease with both initiating and promoting factors participating in it's development. In studies with rabbits fed with a diet of 0.5% DHEA elevating their DHEA levels six-fold, a 50% reduction in atherosclerosis was observed as compared to placebo.

In studies with humans, it has been reported that the DHEA-Sulfate level is independently and inversely related to death from any cause and death from cardiovascular disease in men older than 50. In a study of 242 men between 50 and 79, a DHEA-S level below 1.4 mg/ml was associated with a 1.5 fold higher death rate from any cause, a 3.3 fold higher death rate from cardiovascular disease, and a 3.2 fold higher death rate from ischemic heart disease. As suggested by the rabbit studies, the determination of baseline DHEA and DHEA-S level in younger men, and proper administration in advancing years, could be useful in helping to avoid cardiovascular disease.

DHEA's Effect on Bone

There is circumstantial evidence for the effect of DHEA on bone in humans. Decreased DHEA levels have been observed in women with decreased vertebral density and forearm mineral content. Women with Addison's Disease also have reduced forearm bone density and lower DHEA levels than age-matched postmenopausal controls.

DHEA's Effect on Thyroid

In animal studies, laboratory induced thyroid gland tumors have been prevented by dietary DHEA therapy. In humans, thyroid dysfunction is associated with DHEA and DHEA-S metabolism alterations. In women with primary hyperthyroidism, DHEA-S levels are reduced as compared to controls. In contrast, women with hyperthyroidism have elevated DHEA-S levels.

DHEA's Effect on Malignancies

In animal studies, the administration of DHEA has been shown to be effective in the prevention or delay of carcinogen-induced mammary, colon, lung, and skin neoplasms. All of these studies have generated the conclusion that DHEA administration may be useful as a chemopreventive agent, and provide the rationale for additional efficacy studies to test the chemopreventive effect of DHEA on humans.

Purity

DHEA is a naturally produced steroid hormone. Therefore, in order to produce a desired effect through administration, it is necessary to produce DHEA at purity levels as close as possible to the DHEA produced by the various steroidogenic tissues of the human body. Discovery Experimental & Development, Inc. has always felt that the majority of the pharmaceuticals produced today are of purity levels that are less than desirable. Testing of several products have substantiated that feeling. For this reason, Discovery produces products at the highest stable purity levels. Usually 99.99+%. Discovery has found that pharmaceutical products produced at their highest purity levels are more potent, more effective, more stable, and cause the least amount of side effects. DHEA is no exception.

References

1.

Loria RM, Inge TH, Cook SS, Szakal AK, Regelson W: Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). J Med Viro 1988;26:301-14

2.

Henderson E, Schwartz A, Pashko L, Abou-Gharbia M, Swern D: Dehydroepiandrosterone and 16a-bromo-epiandrosterone: inhibitors of Epstein-Barr virus-induced transformation of human lymphocytes; Carcinogenesis, Vol 2(7)683-6

3.

Membreno L, Irony I, Dere W, Klein R, Biglieri EG, Cobb E: Adrenocortical Function in Acquired Immunodeficiency Syndrome; Journal of Clinical Endrocrinology and Metabolism 65(3)482-7

4.

Polk BF, Fox R, et al: Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men; The New England Journal oF Medicine 316(2)61-6

5.

Moss AR, Bacchetti P, Osmond D, et al: Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort; British Medical Journal 296, 745-750

7

Fahey JK, Taylor JMG, Detels R, et al.: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virs type 1; N Engl J Med 1990;322:16672

8.

deWolf F, Lange JMA Houweling JTM, et al.: Number of CF4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among serpositive homosexual men. J Infect Dis 1988;158:615-22

9.

Jacobson MA, Fusaro RE, Galmarini M, Lang W: Decreased Serum Dehydroepiandrosterone Is Associated with an Increased Progression of Human Immunodeficiency Virus Infection in Men with CD4 Cell Counts of 200-499; The Journal of Infectious Diseases 164:864-8 (1991)

10.

Boccuzzi G, Brignardello E, Di Monaco M, Forte C, Leonardi L, Pizzini A: Influence of Dehydroepiandrosterone and 5-En-andostene-3 Beta, 17 Beta-diol on the Growth of MCF-7 Human Breast Cancer Cells Induced by 17 Beta-Estradiol; Anticanncer Research 12:799-804(1992)

11.

Daynes RA, Dudley DJ, Araneo BA: Regulation of murine lymphokine production in vivo, II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 systhesis by helper T cells; Eur J. Immunol 20:793-802 (1990)

12.

Barrett-Conner E, Khaw K, Yen SSC: A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular Disease; The New England Journal of Medicine 315(24)151924 (1986)

13.

Nestler JE, Barlascini CO, Clore JN, Blackard WG: Dehydroepiandrosterone Reduces Serum Low Density Lipoprotein Levels and Body Fat but Does not Alter Insulin Sensitivity in Normal Men; Journal of Clinical Endocrinology and Metabolism 66(1)57-61 (1988)

14.

Goedert JJ, Biggar RJ, Melbye M et al: Effect of T4 Count and Cofactors on the Incidence of AIDS in Homosexual Men infected With Human Immunodeficiency Virus; Journal of the American Medical Association 257(3)331-4 (1987)

15.

Winkelstein W, Lyman DM, Padian N, et al.: Sexual Practices and Risk of Infection by the Human Immunodeficiency Virus; Journal of the American Medical Association, 257(3)321-5 (1987)

16.

Ohno T, Imai A, Tamaya T: Possible evidence that Dehydroepiandrosterone Sulfate (DHA-S) Stimulates Cervical Ripening by a Membrane-Mediated Process: Specific Binding Sites in Plasma Membrane from Human Uterine Cervix; Research Communications in Chemical Pathology and Pharmacology 72(1)117-20 (1991)

17.

Steinberg KK, Freni-Titulaer LW, DePuey EG, et al: Sex Steroids and Bone Density in Premenopausal and Perimenopausal Women; Journal of Clinical Endocrinology and Metabolism, 69(3):533-539

18.

Stahl F, Schnorr D, Pilz C, Dorner G: Dehydroepiandrosterone (DHEA) Levels in Patients With Prostatic Cancer, Heart Diseases and Under Surgery Stress, Exp Clin Endocrinol 99:68-70 (1992)

19.

Spector TD, Thompson PW, Perry LA, et al: The Relationship Between sex steroids and Bone Mineral Content in Women Soon After the Menopause; Clinical Endocrinology 34:37-41 (1991)

20.

Schneider LS, Hinsey M, Lyness S: Plasma Dehydroepiandrosterone Sulfate in Alzheimer's Disease; Biol Psychiatry 31:205-208 (1992)

21.

Schlaghecke R, Beuscher D, Kley HK, Juli E: Age-Related Changes in 11-Beta-Hydroxylandrostenedione Concentration in Normal and Osteoporotic Women; J. Steroi Biochem Molec. Biol 40(6)731-733 (1991)

22.

Sambrook P, Birmingham J, Champion D, et al: Postmenopausal Bone Loss in Rheumatoid Arthritis: Effect of Estrogens and Androgens; Journal of Rheumatology 19(3)357-361 (1992)

23.

Sambrook PN, Eisman JA, Champion GD, Pocock NA: Sex Hormon Status and Osteoporosis in Postmenopausual Women with Rheumatoid Arthritis; Arthritis and Rheumatism 31(8):973-8 (1988)

24.

Salvini S, Sampfer MJ, Barbieri RL, Hennekens CH: Effects of Age, Smoking and Vitamins on Plasma DHEA Levels: A Cross-Sectional Study in Men; Journal of Clinical Endocrinology and Metagolism 74(1):139-43 (1992)

25.

Rozenberg S, Ham H, Bosson D, Peretz A, Robyn C: Age, Steroids, and Bone Mineral Content, Maturitas 12:137-43 (1990)

26.

Parlati E, Liberale I, Travaglini A, Morelli P, et al: Prolactin Secretion and Dehydroepiandrosterone Suphate Plsma Levels in Women with Benign Breast Disease; J. Endocrinol Invest 12:549-52 (1989)

27.

Mortola JF, Yen SSC: The Effects of Oral Dehydroepiandrosterone on Endocrine-Metabolic Parameters in Postmenopausal Women 71(1)696-704 (1990)

28.

Horowitz M, Wishart JM, O'Loughlin PD, et al: Osteoporosis and Klinefelter's Syndrome; Clinical Endocrinology 36:113-8 (1992)

29.

Haning RV, Chabot M, et al: Metabolic Clearance Rate (MCR) of Dehydroepiandrosterone Sulfate (DS), Its Metabolism ot Dehydroepiandrosterone, Androstenedione, Testosterone, and ihydrotestosterone, and the Effect of Increased Plasma DS Concentration on DS MCR in Normal Women; Journal of Clinical Endocrinology and Metabolism 69(5):1047-52 (1989)

30.

Gordon GB, Bush TL, et al: Relationship of Serum Levels of Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate to the Risk of Developing Postmenopausal Breast Cancer; Cancer Research 50:3859-62 (1990)

31.

Diamond MP, Grainger DA, Laudano AJ, et al: Effect of Acute Physiological Elevations of Insulin on Circulating Androgen Levels in Nonobese Women; Journal of Clinical Endocrinology and Metabolism 72(4)883-7 (1991)

32.

Buster JE, Casson PR, Straugn AB, et al: Postmenopausal Steroid Replacement with Micronized Dehydroepiandrosterone: Preliminary Oral Bioavailability and Dose Proportionality Studies; Am J Obstet Genecol 166:1163-70 (1992)

33.

Svec F, Lopez A: Antiglucocorticoid Actions of Dehydroepiandrosterone and Low Concentrations in Alzheimer's Disease; The Lancet:1335-6 (12/2/89)

Home > Product Information > Pro-Cell 40